Department Of Psychiatry 3
101. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
102. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
103. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
104. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
105. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
106. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
107. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
108. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
109. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
110. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
111. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
112. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
113. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
114. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
115. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
116. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
117. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
118. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
119. Compounding vulnerabilities: victimization and discrimination is associated with COVID-19 disruptions to HIV-related care among gay, bisexual, and other men and transgender and nonbinary people who have sex with men in Kazakhstan
120. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
121. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
122. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
123. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
124. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
125. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019
126. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
127. Effect of work schedule flexibility as a moderator in the relationship between job stress and wellbeing in pharmacy practice
128. Leveraging digital skills to reduce cognitive strain: Implications for academic self-efficacy in medical education
129. Potential Correlation Between Self-Compassion and Bedtime Procrastination: The Mediating Role of Emotion Regulation
130. Potential determinants of vaccine hesitancy among celiac disease patients: a single cohort analysis
131. Psychological dynamics of pandemic resilience: a tale of two cultures
132. Rumination and Coping as Pathways from Stress to Emotional Exhaustion among Hospital Pharmacists
133. The buffering effects of mindfulness and organizational support on the mental health of hospital pharmacists in high-workload environments
134. The Mediating Roles of Self-Compassion and Emotion Regulation in the Relationship Between Psychological Resilience and Mental Health Among College Teachers
135. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
136. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
137. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
138. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
139. ‘We are all in the same boat’: How societal discontent affects intention to help during the COVID-19 pandemic
140. The Fear of COVID-19 Scale: Its Structure and Measurement Invariance Across 48 Countries
141. Mapping routine measles vaccination in low- and middle-income countries
142. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
143. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
144. Is the Association between Suicide and Unemployment Common or Different among the Post-Soviet Countries?
145. Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
146. Therapeutic and Toxic Effects of Valproic Acid Metabolites
147. Living with peripartum cardiomyopathy: A statement from the Heart Failure Association and the Association of Cardiovascular Nursing and Allied Professions of the European Society of Cardiology
148. Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses
149. Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study
150. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
1 2 3 4